Research progress on ocular complications of blepharoplasty and cosmetic enhancements

doi:10.3877/cma.j.issn.2095-2007.2025.03.008

Abstract

Abstract:

In recent years, with the advancement of aesthetic concepts and the increasing demand for beauty, aesthetic surgeries related to the eyes have gradually become a popular and emerging topic. Double eyelid surgery, the application of beauty products, and injectable aesthetics are the primary methods of eye-related aesthetic surgeries. Common complications of double eyelid surgery include asymmetry of the double eyelids, disappearance of the double eyelids, hematoma, infection, ptosis, dry eye, and keratitis related to buried sutures. Complications caused by beauty products include infectious ocular surface diseases, immune-related ocular surface diseases, hypopigmentation of the eyelids due to melanocyte reduction, and uveitis. Complications of injectable aesthetics include retinal artery occlusion, tissue edema, characteristic bluish-gray changes in the eyelid injection area, delayed nodules, periorbital swelling, and ptosis. Currently, the research on the pathogenesis of various complications in eye-related aesthetic surgeries is not yet fully understood, and there is room for improvement in their prevention and treatment measures. The methods of eye-related aesthetic surgeries require further development in material selection, surgical innovation, and optimization studies. Additionally, there is a need for the early establishment of expert consensus and standards regarding the techniques of double eyelid surgery, the use of beauty products, and injectable aesthetics. In this paper, the principles of these aesthetic methods and the pathogenesis, treatment methods, and preventive measures for their associated ocular complications was reviewed.

Key words: Double eyelid surgery, Mascara, Eyeliner, Permanent eyeliner tattoo, Eyelash lengthening, Cosmetic contact lens, Aesthetic injection

Hongling Wu, Hong Zhang. Research progress on ocular complications of blepharoplasty and cosmetic enhancements[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2025, 15(03): 171-175.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhykyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2007.2025.03.008

https://zhykyxzz.cma-cmc.com.cn/EN/Y2025/V15/I03/171

References 65

[1]	Hwang HS, Spiege JH. The effect of " single" vs " double" eyelids on the perceived attractiveness of Chinese women[J]. Aesthet Surg J, 2014, 34(3): 374-382.
[2]	Fu L, Wasielica－Poslednik J, Geerling G, et al. Navigating the Challenges of Acanthamoeba Keratitis[J]. Life (Basel), 2025, 15(6): 933.
[3]	Sayoc BT. Absence of superior palpebral fold in slit eyes, an anatomic and physiologic explanation[J]. Am J Ophthalmol, 1956, 42(2): 298-300.
[4]	张之璐，王永前. 埋线法重睑成形术研究进展[J]. 组织工程与重建外科杂志，2021,17(4): 368-372.
[5]	王晓凤，方青青，陈春野，等. 亚洲人重睑成形术的研究进展[J]. 中国美容医学，2017,26(2):135-139.
[6]	朱吉凤，刘新昊，杨天荣. 重睑成形术的应用进展[J]. 中国医疗美容，2021,11(2):101-105.
[7]	Rohrich RJ, Avashia YJ, Savetsky IL. Cosmetic Surgery Safety: Putting the Scientific Data into Perspective[J]. Plast Reconstr Surg, 2020, 146(2): 295-299.
[8]	Sagiv O, Rosenfeld E, Kalderon E, et al. Subcutaneous tranexamic acid in upper eyelid blepharoplasty[J]. Can J Ophthalmol, 2018, 53(6): 600-604.
[9]	Chen YA, Singghal D, Chen YR, et al. Management of acute traumatic retrobulbar haematomas: a 10－year retrospective review[J]. J Plast Reconstr Aesthet Surg, 2012, 65(10): 1325-1330.
[10]	Colletti G, Valassine D, Rabbiosi D, et al. Traumatic and iatrogenic retrobulbar hemorrhage[J]. J Oral Maxillofac Surg, 2012, 70(8): e464-e468.
[11]	Rosdeutscher JD, Stadelmann WK. Diagnosis and treatment of retrobulbar hematoma resulting from blunt periorbital trauma[J]. Ann Plast Surg, 1998, 41(6): 618-622.
[12]	Distefano AG, Pasol J. Posterior Ischemic Optic Neuropathy After Blepharoplasty[J]. J Neuroophthalmol, 2018, 38(2): 200-201.
[13]	Christie B, Block L, Ma Y, et al. Retrobulbar hematoma: A systematic review of factors related to outcomes[J]. J Plast Reconstr Aesthet Surg, 2018, 71(2): 155-161.
[14]	Verfaillie G, Knape S, Corne L. A case of fatal necrotizing fasciitis after intramuscular administration of diclofenac[J]. Eur J Emerg Med, 2002, 9(3): 270-273.
[15]	Wilson B. Necrotizing fasciitis[J]. Am Surg, 1952, 18(4): 416-431.
[16]	Baiu I, Melendez E. Periorbital and Orbital Cellulitis[J]. Jama, 2020, 323(2): 196.
[17]	Christie B, Block L, Ma Y, et al. Retrobulbar hematoma: A systematic review of factors related to outcomes[J]. J Plast Reconstr Aesthet Surg, 2018, 71(2): 155-161.
[18]	Chiu ES, Capell BC, Press R, et al. Successful management of orbital cellulitis and temporary visual loss after blepharoplasty[J]. Plast Reconstr Surg, 2006, 118(3): 67-72.
[19]	Liu J, Song B. Review of complications in double eyelid surgery[J]. Indian J Ophthalmol, 2022, 70(5): 1460-1465.
[20]	Ren Y, Xiao H, Wu YH, et al. Sentinel Artery in Double Eyelid Blepharoplasty: Identification, Prevention, Management[J]. J Craniofac Surg, 2017, 28(6): 1435-1436.
[21]	Guyton DL. The posterior fixation procedure: mechanism and indications[J]. Int Ophthalmol Clin, 1985, 25(4): 79-88.
[22]	Prischmann J, Sufyan A, Ting JY, et al. Dry eye symptoms and chemosis following blepharoplasty[J]. JAMA Facial Plast Surg, 2013, 15(1): 39-46.
[23]	Yan Y, Zhou Y, Zhang S, et al. Impact of Full－Incision Double－Eyelid Blepharoplasty on Tear Film Dynamics and Dry Eye Symptoms in Young Asian Females[J]. Aesthetic Plast Surg, 2020, 44(6): 2109-2116.
[24]	Mai H, Kuo B I, Hou YC. Recurrent corneal erosion caused by retained sutures in blepharoplasty[J]. Int Ophthalmol, 2019, 39(6): 1387-1390.
[25]	Li SM, Jin X, Zhang N, et al. A case of corneal and conjunctival damage caused by suture exposure after buried－suture clouble－eyelid blepharoplasty[J]. Zhonghua Yan Ke Za Zhi, 2025, 61(2): 131-134.
[26]	Ortiz AE, Alster TS. Rising concern over cosmetic tattoos[J]. Dermatol Surg, 2012, 38(3): 424-429.
[27]	Ullrich K, Saha N. Semipermanent eyelash extensions causing bacterial keratitis: a case report[J]. Can J Ophthalmol, 2013, 48(3): 50-51.
[28]	Chan KY, Cho P, Boost M. Microbial adherence to cosmetic contact lenses[J]. Cont Lens Anterior Eye, 2014, 37(4): 267-272.
[29]	Lee SM, Lee JE, Lee DI, et al. Adhesion of Acanthamoeba on Cosmetic Contact Lenses[J]. J Korean Med Sci, 2018, 33(4): 26.
[30]	Ono K, Murakami A, Haishima Y. A web－based survey of contact lens－related adverse events among the Japanese female population[J]. Sci Rep, 2021, 11(1): 15939.
[31]	Amano Y, Sugimoto Y, Sugita M. Ocular disorders due to eyelash extensions[J]. Cornea, 2012, 31(2): 121-125.
[32]	Paimela T, Ryhänen T, Kauppinen A, et al. The preservative polyquaternium－1 increases cytoxicity and NF－kappaB linked inflammation in human corneal epithelial cells[J]. Mol Vis, 2012, 18: 1189-1196.
[33]	Chen X, Sullivan DA, Sullivan AG, et al. Toxicity of cosmetic preservatives on human ocular surface and adnexal cells[J]. Exp Eye Res, 2018, 170: 188-197.
[34]	Moshirfar M, Masud M, Shah TJ, et al. Chemical conjunctivitis and diffuse lamellar keratitis after removal of eyelash extensions[J]. Am J Ophthalmol Case Rep, 2018, 12: 21-23.
[35]	Choi SM, Roh TH, Lim DS, et al. Risk assessment of benzalkonium chloride in cosmetic products[J]. J Toxicol Environ Health B Crit Rev, 2018, 21(1): 8-23.
[36]	Mondéjar－López M, López－Jiménez AJ, Abad－Jordá M, et al. Biogenic Silver Nanoparticles from Iris tuberosa as Potential Preservative in Cosmetic Products[J]. Molecules, 2021, 26(15): 4696.
[37]	Liao JC, Proia AD, Ely PH, et al. Late－onset melanopenic hypomelanosis as a complication of cosmetic eyeliner tattoo[J]. J Am Acad Dermatol, 2013, 69(3): 144-146.
[38]	吴溯帆，孙燚. 面部注射材料选择的解剖学逻辑[J]. 中华整形外科杂志，2025,41(2):196-202.
[39]	Casabona G, Alfertshofer M, Kaye K, et al. Ex Vivo Product Distribution of Injectable Biostimulator Substances[J]. Aesthet Surg J, 2023, 43(5): 348-356.
[40]	Aguilera SB, Mccarthy A, Khalifian S, et al. The Role of Calcium Hydroxylapatite (Radiesse) as a Regenerative Aesthetic Treatment[J]. Aesthet Surg J, 2023, 43(10): 1063-1090.
[41]	Foster J, Aakalu VK, Freitag SK, et al. Vision－Threatening Complications of Soft Tissue Fillers[J]. Ophthalmology, 2025, 31: S0161.
[42]	Tansatit T, Moon HJ, Apinuntrum P, et al. Verification of Embolic Channel Causing Blindness Following Filler Injection[J]. Aesthetic Plast Surg, 2015, 39(1): 154-161.
[43]	Delorenzi C. Complications of injectable fillers, part 2: vascular complications[J]. Aesthet Surg J, 2014, 34(4): 584-600.
[44]	Wang Y, Li Q, Ye Y, et al. Intraarterial Thrombolytic Treatment for Visual Deficits Caused by Hyaluronic Acid Filler[J]. Plast Reconstr Surg, 2023, 152(6): 1226-1233.
[45]	Sharad J. Dermal Fillers for the Treatment of Tear Trough Deformity: A Review of Anatomy, Treatment Techniques, and their Outcomes[J]. J Cutan Aesthet Surg, 2012, 5(4): 229-238.
[46]	Skippen B, Baldelli I, Hartstein M, et al. Rehabilitation of the Dysmorphic Lower Eyelid From Hyaluronic Acid Filler[J]. Aesthet Surg J, 2020, 40(2): 197-205.
[47]	Vasquez RAS, Park K, Braunlich K, et al. Prolonged Periorbicular Edema After Injection of Hyaluronic Acid for Nasojugal Groove Correction[J]. J Clin Aesthet Dermatol, 2019, 12(9): 32-35.
[48]	Decates TS, Velthuis PJ, Schelike LW, et al. Increased risk of late－onset, immune－mediated, adverse reactions related to dermal fillers in patients bearing HLA－B08 and DRB103 haplotypes[J]. Dermatol Ther, 2021, 34(1): 14644.
[49]	Urdiales－Gálvez F, Delgado NE, Figueiredo V, et al. Treatment of Soft Tissue Filler Complications[J]. Aesthetic Plast Surg, 2018, 42(2): 498-510.
[50]	Raspaldo H, Gassia V, Niforos FR, et al. Global, 3－dimensional approach to natural rejuvenation[J]. J Cosmet Dermatol, 2012, 11(4): 279-289.
[51]	Haddock NT, Saadeh PB, Boutros S, et al. The tear trough and lid/cheek junction: anatomy and implications for surgical correction[J]. Plast Reconstr Surg, 2009, 123(4): 1332-1340.
[52]	De Pasquale A, Russa G, Pulvirenti M, et al. Hyaluronic acid filler injections for tear－trough deformity[J]. Aesthetic Plast Surg, 2013, 37(3): 587-591.
[53]	Griepentrog GJ, Lemke BN, Burkat CN, et al. Anatomical position of hyaluronic Acid gel following injection to the infraorbital hollows[J]. Ophthalmic Plast Reconstr Surg, 2013, 29(1): 35-39.
[54]	Zoumalan CI. Managing Periocular Filler－Related Syndrome Prior to Lower Blepharoplasty[J]. Aesthetic Plast Surg, 2019, 43(1): 115-122.
[55]	Varga R. Providing Optimal Rejuvenation to the Periocular Area Using Botulinum Toxin A Neuromodulators and Hyaluronic Acid Dermal Fillers[J]. Plast Surg Nurs, 2019, 39(4): 119-124.
[56]	Rao BK, Berger LE, Reilly C, et al. Tear Trough Filler Techniques Utilizing Hyaluronic Acid: A Systematic Review[J]. Plast Reconstr Surg, 2022, 149(5): 1079-1087.
[57]	Trinh LN, Grond SE, Gupta A. Dermal Fillers for Tear Trough Rejuvenation[J]. Facial Plast Surg, 2022, 38(3): 228-239.
[58]	Wang Y, Massry G, Holds JB. Complications of Periocular Dermal Fillers[J]. Facial Plast Surg Clin North Am, 2021, 29(2): 349-357.
[59]	Liu Q, Guo L, Zhu Y, et al. Prospective comparative clinical study[J]. J Cosmet Dermatol, 2024, 23(5): 1613-1619.
[60]	Guduk SS. An Unusual Delayed Type Reaction Following Periorbital Filler Injection With Hyaluronic Acid[J]. Aesthet Surg J, 2018, 38(8): 109-113.
[61]	Sadeghpour M, Quatrano NA, Bonati LM, et al. Delayed－Onset Nodules to Differentially Crosslinked Hyaluronic Acids[J]. Dermatol Surg, 2019, 45(8): 1085-1094.
[62]	Philipp－dormston WG, Goodman GJ, Deboulle K, et al. Global Approaches to the Prevention and Management of Delayed－onset Adverse Reactions with Hyaluronic Acid－based Fillers[J]. Plast Reconstr Surg Glob Open, 2020, 8(4): 2730.
[63]	Bacharach J, Lee WW, Harrison AR, et al. A review of acquired blepharoptosis[J]. Eye (Lond), 2021, 35(9): 2468-2481.
[64]	King M. Management of Ptosis[J]. J Clin Aesthet Dermatol, 2016, 9(12): E1-E4.
[65]	Zou J, Li Z, Li X, et al. Unilateral Blepharoptosis Combined With Malignant Exophthalmos After Botulinum Toxin Injection to Glabellar Lines: A Case Report[J]. J Cosmet Dermatol, 2025, 24(2): 70028.

Please choose a citation manager

Content to export